A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
ILF With/Without Cisplatin for Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
- Status
- TERMINATED
- Phase
- PHASE2
Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2